Financial statements Bellesa-Med
Balance sheet data of BELLESA-MED
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 141 869,39 | 245 201,84 | 839 771,01 | 3 417 728,31 | 4 040 003,39 | 3 702 475,95 |
| A. Fixed assets | 104 399,61 | 32 104,15 | 34 631,95 | 213 161,75 | 106 006,00 | 88 876,67 |
| B. Current assets | 37 469,78 | 213 097,69 | 805 139,06 | 3 204 566,56 | 3 933 997,39 | 3 613 599,28 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | - | - |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | - | - |
| Total liabilities | 141 869,39 | 245 201,84 | 839 771,01 | 3 417 728,31 | 4 040 003,39 | 3 702 475,95 |
| A. Equity | 78 958,30 | 207 243,21 | 764 370,58 | 1 835 692,27 | 3 054 796,34 | 2 698 612,99 |
| B. Liabilities and provisions for liabilities | 62 911,09 | 37 958,63 | 75 400,43 | 1 582 036,04 | 985 207,05 | 1 003 862,96 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | - | - |
| II. Short-term liabilities | 62 911,09 | 37 958,63 | 75 400,43 | 1 582 036,04 | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.